Nordsjællands Hospital Hillerød
- Address
- MS clinic, Dyrlægevej 29, 2900 København s, Denmark
Nordsjællands Hospital Hillerød - Multiple Sclerosis Research Center
Nordsjællands Hospital Hillerød is a dedicated research facility focusing on advancing treatments for neurological disorders, with particular expertise in multiple sclerosis management and therapeutic optimization. The center conducts sophisticated comparative effectiveness studies to evaluate innovative treatment strategies for patients with active forms of this chronic autoimmune condition.
- Non-inferiority trials comparing CD20-depleting monoclonal antibody therapies
- Long-term efficacy and safety evaluation of disease-modifying treatments
- Optimization of dosing strategies and extended interval therapy protocols
The research program includes comprehensive long-term follow-up studies extending up to 60 months, examining both standard and extended interval dosing regimens for established therapies. This extended evaluation approach enables the center to identify optimal treatment strategies that balance efficacy with patient convenience and safety, particularly for individuals who have achieved stability on CD20-depleting therapy. The center's focus on neuroimaging endpoints, including evaluation of new or enlarging T2 white matter lesions, demonstrates a commitment to objective disease monitoring and evidence-based treatment protocols.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nordsjællands Hospital Hillerød
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Non-Inferiority Trial of Ocrelizumab Versus Rituximab in Active Multiple Sclerosis Patients | Region Hovedstaden | Phase III | Not Recruiting | Apr 2021 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ocrelizumab | 1 | Unknown | 2021-04-28 | 2021-04-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.